Guardant Health receives FDA approval for Guardant360® CDX as a companion diagnostic for AstraZeneca’s Etcamah™ (Camizestrant) in advanced breast cancer.

MoveSurge carries market-moving headlines the moment they reach the wire, each one with what the price did next.